A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
NCT03874832
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Migraine With Aura
Migraine Without Aura
Migraine
Interventions
DRUG:
Dihydroergotamine
Sponsor
Satsuma Pharmaceuticals, Inc.